OTX015,BETInhibitor

点击看大图

如果您对该产品感兴趣的话,可以

产品名称: OTX015,BETInhibitor

产品型号: 60193-2s

产品展商: 其它品牌

产品文档: 无相关文档

简单介绍

OTX015,BETInhibitor

OTX015,BETInhibitor 的详细介绍

Product Information

Molecular Weight:	491.99
Formula:	C₂₅H₂₂ClN₅O₂S
Purity:	≥98%
CAS#:	202590-98-5
Solubility:	DMSO up to 100 mM
Chemical Name:	(S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide
Storage:	Powder: 4^oC 1 year. DMSO: 4^oC 3 month; -20^oC 1 year.

Biological Activity:

OTX015 is a novel, highly potent, selective and cell permeable inhibitor of the bromodomain and extra terminal (BET) family proteins BRD2, BRD3 and BRD4 with IC₅₀ of 10-19 nM. It inhibits the growth of a variety of human cancer cell lines with IC₅₀ ranging from 60 to 200 nM. OTX015 results in rapid down-regulation of c-MYC expression, and show the synergistic anti-proliferative effects in combination with ALK inhibitors in ALKpos ALCL cell lines. In vivo studies using OTX015 have demonstrated efficacy in a range of oncology models. OTX015 is currently in phase I clinical development for oncology indication.

How to Use:

In vitro: OTX015 was used at 2-10 µM final concentration in various in vitro assays.
In vivo: OTX015 could be dosed to the mice by oral administration at 100 mg/kg once per day or 10 mg/kg twice per day.

Reference:

1. Noel JK, et al. Development of the BET bromodomain inhibitor OTX015. (2013) Mol Cancer Ther. 12, C244.
2. Boi M, et al. OTX015, a bromodomain and extraterminal inhibitor, represents a novel agent for ALK positive anaplastic large cell lymphoma. (2013) Mol Cancer Ther. 12, A219.

Products are for research use only. Not for human use.

产品留言

标题

联系人

联系电话

内容

验证码

点击换一张

注：1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!